Here's the live share price of Medplus Health Services along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Medplus Health Services has declined 7.43% CAGR. Over the past year, the corresponding return has been 14.03%.
Medplus Health Services’s current P/E of 51.19x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Medplus Health Services | 0.24 | 2.65 | -18.07 | -4.87 | 14.03 | 8.75 | -7.43 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Medplus Health Services has gained 14.03% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Medplus Health Services has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 757.34 | 754.92 |
| 10 | 760.22 | 757.94 |
| 20 | 760.98 | 766.22 |
| 50 | 802.01 | 793.4 |
| 100 | 842.52 | 812.84 |
| 200 | 813.85 | 807.84 |
In the latest quarter, Medplus Health Services saw a drop in promoter holding to 40.29%, while DII stake increased to 26.51%, FII holding rose to 16.53%, and public shareholding moved down to 16.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 39,97,983 | 1 | 302.83 | |
| 36,27,277 | 3.39 | 274.75 | |
| 35,78,425 | 1.55 | 271.05 | |
| 25,27,912 | 0.4 | 191.48 | |
| 24,32,539 | 1.39 | 184.25 | |
| 20,98,553 | 1.88 | 158.95 | |
| 11,32,626 | 0.45 | 85.79 | |
| 10,94,617 | 0.43 | 82.91 | |
| 9,37,074 | 1.14 | 70.98 | |
| 7,15,753 | 0.18 | 54.21 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 1:10 AM IST | Medplus Health Serv - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Oct 31, 2025, 11:34 PM IST | Medplus Health Serv - Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025 |
| Oct 31, 2025, 10:45 PM IST | Medplus Health Serv - Board Meeting Outcome for Un-Audited Financial Results Of The Company For The Quarter And Half Year End |
| Oct 23, 2025, 12:18 AM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
| Oct 16, 2025, 12:22 AM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Medplus Health Services Ltd. is a Public Limited Listed company incorporated on 30/11/2006 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85110TG2006PLC051845 and registration number is 051845. Currently Company is involved in the business activities of Retail sale of pharmaceuticals, medical and orthopaedic goods and toilet articles. Company's Total Operating Revenue is Rs. 713.10 Cr. and Equity Capital is Rs. 23.94 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Medplus Health Services is ₹761.85 as on Oct 31, 2025.
The Medplus Health Services is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Medplus Health Services is ₹9,128.68 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Medplus Health Services are ₹765.00 and ₹755.60.
The 52-week high/low is the highest and lowest price at which Medplus Health Services stock has traded in the past 52-week or nearly a year. The 52-week high of Medplus Health Services is ₹1,052.05 and 52-week low of Medplus Health Services is ₹603.00 as on Oct 31, 2025.
The Medplus Health Services has shown returns of 0.77% over the past day, 2.65% for the past month, -18.07% over 3 months, 14.03% over 1 year, 8.75% across 3 years, and -7.43% over 5 years.
P/E ratio of and PB ratio of Medplus Health Services are 51.19 and 5.24 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.